Microscope Market (2026 - 2033) Size, Share & Trends Analysis Report By Type (Optical, Electron, Scanning Probe), By Application (Nanotechnology, Life Science, Material Science, Semiconductors), By Region, And Segment Forecasts

Microscope Market Summary

The global microscope market size was estimated at USD 11.88 billion in 2025 and is expected to reach USD 21.23 million by 2033, growing at a CAGR of 7.58% from 2026 to 2033. This growth is attributed to the expanding demand from life sciences research, clinical diagnostics, and healthcare applications, supported by continuous growth in biomedical research and disease diagnosis.

Moreover, strong investments in pharmaceutical and biotechnology R&D, growth in academic and research institutes, and increasing government funding for scientific research are boosting microscope adoption. In addition, technological advancements such as high-resolution imaging, digital and fluorescence microscopy, AI-enabled image analysis, and automation are further enhancing usability and accuracy, driving replacement demand and market expansion. 

Growth in Life Sciences, Biotechnology & Drug Discovery

Growth in life sciences, biotechnology, and drug discovery is a major driver for the microscope market, as modern biomedical research increasingly relies on high-resolution imaging to study cells, tissues, and molecular interactions. Advanced microscopy techniques are essential for understanding disease mechanisms, identifying drug targets, evaluating cellular responses, and validating therapeutic efficacy during preclinical and clinical research. The expanding focus on genomics, proteomics, stem cell research, and personalized medicine further increases the need for sophisticated optical, fluorescence, and electron microscopy devices. As per August 2024 updates, Researchers at Ben-Gurion University have leveraged state-of-the-art microscopy techniques to uncover the structural mechanisms by which cells regulate and utilize iron, a process that plays a critical role in cancer progression. Using advanced high-resolution imaging tools, scientists were able to visualize cellular structures and molecular interactions involved in iron metabolism with exceptional precision. As pharmaceutical and biotechnology companies, research institutes, and clinical laboratories continue to scale up R&D activities and adopt advanced imaging technologies, demand for high-performance microscopes grows steadily, directly supporting market expansion.

Case Study by Phys.org Published in August 2024: Low-Dose Event-Based Microscopy Driving Innovation in the Microscope Market

Background:

Conventional scanning transmission electron microscopes (STEMs) use a fixed dwell-time approach, exposing samples to a constant electron beam at every pixel. While effective, this method often results in excessive radiation exposure, leading to damage or structural alteration of sensitive materials such as biological tissues, battery materials, and catalysts. This limitation has long constrained high-resolution imaging in life sciences and advanced materials research.

Innovation:

In August 2024, an international research team led by Trinity College Dublin introduced a breakthrough event-based imaging method for STEM. Instead of measuring signals over a fixed exposure time, the new approach measures the time required to detect a predefined number of electron scattering events. Their research demonstrated that the first detected electrons provide the majority of useful image information, while subsequent electrons contribute diminishing informational value but continue to increase radiation damage. To translate this theory into practice, the team patented Tempo STEM, a technology that integrates a high-speed beam blanker capable of shutting off the electron beam within nanoseconds once optimal image information is obtained.

Market Impact:

This advancement significantly reduces radiation dose and imaging time while maintaining or improving image quality. For the microscopy devices market, it highlights a shift toward smart, adaptive, and low-dose imaging technologies, particularly for applications involving radiation-sensitive samples. Innovation expands the usability of electron microscopes in biomedical research, pathology, nanotechnology, energy storage research, and materials science, where sample integrity is critical.

Strategic Relevance for the Market:

The case underscores how cutting-edge R&D and patented technologies are driving differentiation in the high-end microscopy segment. Manufacturers adopting event-based detection, AI-driven imaging logic, and beam-control technologies can unlock new demand from life sciences, advanced materials, and pharmaceutical research. As users increasingly prioritize sample preservation alongside resolution, such innovations are expected to accelerate upgrades and new installations, acting as a strong growth driver for the global microscope market.

Rising Demand for Medical Diagnostics

Rising demand for medical diagnostics is a major driver for the market, as microscopes are indispensable tools across pathology, microbiology, histology, and infectious disease testing. The growing global burden of chronic conditions such as cancer, cardiovascular diseases, and diabetes, along with the continued prevalence and emergence of infectious diseases, has significantly increased the volume of laboratory testing and diagnostic procedures. Microscopes enable accurate visualization and analysis of tissues, cells, and microorganisms, supporting early disease detection, precise diagnosis, and treatment monitoring. In addition, expanding hospital laboratories, diagnostic centers, and public health surveillance programs particularly in emerging economies are further driving the adoption of advanced optical and digital microscopes, thereby contributing to sustained market growth.

Case Study by National Library of Medicine Published in 2026 January: AI-Supported Digital Microscopy Diagnostics Driving Growth in the Market

Background:

Primary Health Care (PHC) laboratories, particularly in low- and middle-income countries (LMICs), rely heavily on manual microscopy due to its low cost and versatility. However, shortages of trained microscopists, limited infrastructure, and variability in diagnostic quality restrict the effectiveness of traditional microscopy at the primary care level. The emergence of AI-supported digital microscopy is addressing these challenges by combining affordable digital microscopes with artificial intelligence to automate and support diagnostic workflows.

Case Overview:

A 2024 scoping review titled “AI-Supported Digital Microscopy Diagnostics in Primary Health Care Laboratories” analyzed peer-reviewed studies evaluating the use of AI-enabled digital microscopy in PHC settings. The review screened over 3,400 publications and included 22 diagnostic accuracy studies conducted in real-world primary care laboratory environments. These studies assessed AI-supported digital microscopy across a wide range of sample types, including blood, urine, stool, sputum, and cytology specimens.

Technology & Application:

The studies evaluated both conventional microscopes retrofitted with digital imaging and purpose-built low-cost digital microscope scanners integrated with AI algorithms, primarily deep learning models such as convolutional neural networks. Applications included:

• Malaria detection and complete blood counts from blood smears
• Parasite detection in stool and urine samples
• Cervical and oral cytology screening
• Detection of pulmonary inflammation and urinalysis abnormalities

AI-supported systems were designed to function in expert-scarce settings, enabling on-site diagnostics with minimal reliance on pathologists.

Key Outcomes:

• AI-supported digital microscopy achieved diagnostic accuracy comparable to standard reference methods across multiple disease areas.
• In 85.7% of relevant studies, AI-based systems demonstrated higher diagnostic sensitivity than manual microscopy.
• Technology showed strong potential to improve diagnostic speed, consistency, and access, particularly in resource-limited and rural settings.

Market Implications:

This case study highlights AI-supported digital microscopy as a transformational growth driver for the microscopy devices market. The clinical reliability demonstrated AI-enabled digital microscopes is accelerating adoption beyond tertiary hospitals into primary care laboratories. Demand is rising for:

• Cost effective digital microscopes compatible with AI software
• Portable and point-of-care microscopy solutions
• Integrated systems supporting telepathology and remote supervision

Governments, global health organizations, and healthcare providers are increasingly investing in such technologies to strengthen diagnostic capacity and reduce health inequities.

Conclusion:

The successful implementation of AI-supported digital microscopy in PHC laboratories underscores a shift in the microscope market toward intelligent, digital, and decentralized diagnostic solutions. As scalability, cost-effectiveness, and regulatory pathways improve, AI-enabled digital microscopes are expected to see strong adoption, particularly in emerging markets, positioning them as a key growth segment within the global microscope market.

Increased R&D Investments

Increased R&D investments act as a strong growth driver for the microscope market, as rising funding from governments, academic institutions, and private enterprises significantly expands research activities across life sciences, materials science, and nanotechnology. Higher R&D budgets enable laboratories to invest in advanced microscopy technologies for detailed cellular analysis, molecular imaging, and nanoscale characterization. As research complexity increases, end users increasingly upgrade from conventional systems to high-resolution, automated, and digital microscopes to improve accuracy, throughput, and reproducibility. Moreover, sustained R&D spending supports long-term procurement cycles, equipment replacement, and technology upgrades, thereby directly boosting demand for microscopes across academic, clinical, and industrial research settings.

Emerging Market Growth & Healthcare Infrastructure

Emerging market growth and expanding healthcare infrastructure act as a strong driver for the microscope market, particularly in regions such as Asia-Pacific and Latin America. The World Bank Group’s initiative launched in December 2025, to deliver affordable, quality health services to 1.5 billion people by 2030 is gaining momentum as countries adopt National Health Compacts focused on strengthening primary health care systems. The goal was announced in April 2024, coordinated efforts by the World Bank Group and its partners have already enabled 375 million people to access quality, affordable care, with active engagement now underway in around 45 countries.

Ajay Banga, World Bank Group President said:

“Strong primary health systems do more than safeguard health-they support jobs and economic opportunity,” “Countries are stepping forward with clear priorities, and we are working alongside them to deliver practical solutions at scale. When efforts align behind what works, impact grows.”

Rapid economic development in these regions is enabling higher public and private investments in healthcare systems, research laboratories, and diagnostic facilities. Governments are prioritizing healthcare modernization through increased funding, establishment of new hospitals, pathology labs, and medical colleges, and expansion of disease surveillance and diagnostic programs. This drives demand for microscopes across clinical diagnostics, pathology, microbiology, and medical education. For instance, in November 2025, Deep tech company Chromodynamics secured USD 2.32 million in Seed funding from investment firm KIKK Capital to advance the development and commercial launch of its next-generation microscopy platform for biomedical research.

Wouter Vijvers, founder and CEO of Chromodynamics said:

“Over the past years, we have done so much market validation and technology development to prove that we have a winner in our hands. Now, we can enter the next phase. Our solution improves upon the state-of-the-art by an order of magnitude on all important performance metrics (throughput, ease-of-use, level of detail), while dramatically reducing costs for the customer.”

In addition, growing awareness of early disease detection, rising patient volumes, and increasing adoption of advanced diagnostic technologies encourage healthcare providers to procure modern optical and digital microscopes. World Chagas Disease Day held in April 2024 aims to give early diagnosis and care for life highlights the global need to address Chagas disease as a long-term, often silent public health challenge. The 2024 observance emphasizes that early diagnosis is critical, as most infected individuals remain asymptomatic for years while the disease progressively damages the heart and digestive system. By promoting timely screening, especially among vulnerable and underserved populations, the initiative aims to prevent severe complications and reduce disease-related mortality.

Alongside healthcare, expanding academic research and life-science activities in emerging economies further support sustained demand, making infrastructure development in these regions a key growth driver for the market. 

Market Characteristics & Concentration

The chart below represents the relationship between industry concentration, industry characteristics, and industry participants. There is a high degree of innovation, moderate level of merger & acquisition activities, high impact of regulations, and moderate expansion of industry.

The industry is experiencing a high degree of innovation. For instance, in July 2024, Medprime Technologies launched Micalys, an innovative AI-integrated digital microscopy platform designed to transform diagnostic workflows by combining high-resolution digital imaging with advanced artificial intelligence capabilities. The platform enables automated slide scanning, image analysis, and AI-driven decision support, reducing dependence on manual microscopy and addressing the shortage of skilled microscopists.

Several key players are actively engaging in mergers & acquisitions to promote growth & innovation and improve their competitiveness by combining the expertise & efforts of different organizations. For instance, in January 2024, Bruker Corporation acquired Nion, a U.S.-based developer of high-end scanning transmission electron microscopes (STEM). This strategic acquisition brings Nion’s advanced electron microscopy technology and expertise into Bruker’s portfolio, expanding its offerings in materials science research and supporting new applications such as electron diffraction crystallography.

Dr. Frank Burgaezy, the Bruker AXS division president said:

“Nion has unique products for the most demanding research applications in materials science electron microscopy, and Bruker will offer Nion global market reach as well as collaborations on new developments to enter new applications in electron diffraction crystallography based on Nion electron microscope and Bruker crystallography technologies.”

Regulations in the market play a critical role in ensuring product safety, performance reliability, and diagnostic accuracy, particularly for microscopes used in clinical and medical applications. For instance, in the U.S., clinical microscopes are regulated by the FDA and must meet requirements under the Medical Device Amendments, including compliance with Quality System Regulations (QSR) and, in some cases, premarket notification or clearance. In Europe, microscopes intended for medical or diagnostic use must comply with the Medical Device Regulation (MDR), which emphasizes clinical evidence, risk management, and post-market surveillance. In addition, manufacturers must adhere to international standards such as ISO 13485 for quality management systems and IEC standards for electrical safety and electromagnetic compatibility.

In October 2024, CrestOptics and Leica Microsystems announces a collaboration to expand capabilities of spinning disk microscopy reflects a growing industry focus on high-performance, user-friendly advanced imaging solutions for life science research. This collaboration enables researchers to capture high-resolution images with minimal phototoxicity, making spinning disk microscopy more accessible for applications such as cell biology, neuroscience, and drug discovery.

Renato Giacobbo Scavo, CEO, CrestOptics, said

“Leica Microsystems provide a wide array of unique and powerful solutions for the imaging market, including the Thunder platform, Adaptive Immersion and many more. By partnering with Leica, we are helping to bring these solutions to the spinning disk microscopy market for the first time, allowing customers to leverage the benefits of these technologies in parallel with Cicero’s confocal imaging capabilities for high resolution imaging of large, often challenging, 3D samples.” 

Type Insights

Based on type, electron microscope segment held a significant share of 41.97% in 2025. This is driven by the growing need for ultra-high-resolution imaging across materials science, nanotechnology, semiconductors, and life sciences. As device reduction accelerates in the semiconductor and electronics industries, electron microscopes such as scanning electron microscopes (SEM) and transmission electron microscopes (TEM) are essential for failure analysis, quality control, and nanoscale characterization. Increasing investments in nanotechnology research, advanced materials, and energy storage systems (including batteries and fuel cells) further fuel demand, as these applications require detailed structural and compositional analysis at the atomic level.

The scanning probes microscopes segment is expected to grow at the fastest CAGR during the forecast period driven by the increasing demand for high-resolution imaging and analysis at the nanoscale across multiple industries. Advancements in nanotechnology and materials science have created a strong need for precise surface characterization, enabling researchers to study atomic- and molecular-level structures, properties, and interactions. SPMs, including atomic force microscopes (AFM) and scanning tunneling microscopes (STM), are widely used in semiconductor research, electronics, polymers, and biomaterials, where detailed nanoscale insights are critical for innovation and quality control.

Application Insights

Based on application, the life science segment held a significant share of 32.38% in 2025. This growth is primarily driven by the rapid expansion of biomedical research, biotechnology, and pharmaceutical development globally. Microscopes are essential tools for studying cellular structures, molecular interactions, and biological processes, making them indispensable in areas such as genomics, proteomics, cell biology, microbiology, and pathology. Moreover, rising investments in drug discovery, vaccine development, and personalized medicine are significantly increasing demand for advanced microscopy techniques, including confocal, fluorescence, super-resolution, and digital microscopy. 

The semiconductors segment is expected to grow at the fastest CAGR during the forecast period as modern microscopy increasingly relies on advanced imaging, automation, and digital data processing. Semiconductor components, including high-performance processors, sensors, and memory chips, are essential for powering high-resolution digital microscopes, confocal systems, and electron microscopes, enabling precise image acquisition, real-time analysis, and 3D reconstruction.

Regional Insights

North America Microscope Market Trends

North America held the largest revenue share of 38.87% in 2025 owing regions strong research infrastructure, high technological adoption, and diverse industrial and scientific applications that together create sustained demand for advanced optical imaging solutions. The region led by the U.S. with its substantial investments in R&D, well-funded academic institutions, and world-class biomedical and life sciences research facilities requires high-precision visualization tools for cellular biology, materials science, and diagnostic workflows, which bolsters the uptake of microscopes in laboratories and clinical environments

U.S. Microscope Market Trends

The U.S. microscope market is experiencing significant growth, driven by the new development and product launches. For instance, in November 2024 ASH launched a 4K digital microscope integrated with advanced imaging and measurement software highlighting the industry’s shift toward high-precision, digital-first microscopy solutions. Coupled with advanced measurement and analysis software, the microscope allows for real-time dimensional analysis, annotation, documentation, and data sharing, improving workflow efficiency and repeatability.

Asia Pacific Microscope Market Trends

Asia Pacific is expected to grow at the fastest CAGR during the forecast period. This is due to driven by rapid adoption across research, healthcare, industrial, and educational sectors. Rapid industrialization and expansion of manufacturing hubs particularly in electronics, semiconductors, and precision engineering have increased the demand for high-precision visual inspection tools used in quality control, defect analysis, and micro-assembly tasks. This is especially pronounced in countries such as China and Japan where large electronics and automotive sectors prioritize reliable stereo imaging for detailed component inspection.

Japan microscope market held significant revenue share in 2025. The development launch of the AR-enhanced stereo microscope by Evident specifically the SZX-AR1 system in July 2022, overlays work instructions and visual guidance directly into the microscope’s field of view is acting as an important market driver for the microscope market in Japan. By integrating augmented reality (AR) technology into traditional microscopes, this innovation significantly improves inspection, assembly, and training efficiency for precision manufacturing and quality control tasks, reducing the need for operators to constantly look away from the eyepiece to consult instructions and thereby lowering error rates and physical strain.

India microscope market is driven by the presence and growth of microscope manufacturers in the country as highlighted in the ESAW India article published in August 2025 is a significant driver for the microscope market in the country as it boosts domestic availability, affordability, and technological relevance of these instruments. Indian manufacturers now produce a wide range of microscopes, including microscopes that offer three-dimensional visualization for quality control, dissection, and industrial inspection, meeting the needs of education, research, healthcare, and industrial labs across India.

Europe Microscope Market Trends

The market in Europe is expected to witness high growth owing to the strong research activity, industrial demand, and technological innovation that together support robust adoption across scientific, healthcare, and quality-control applications. Europe’s well-established life sciences and materials research infrastructure, supported by significant public and private R&D funding (including programs such as Horizon Europe), fuels demand for high-precision imaging tools microscopes are essential for detailed 3D visualization in biological, cellular, and materials studies.

The Germany microscope market held a significant share in the Europe industry owing to the new product developments and innovative offerings. For instance, in March 2024, UC Enuity represented the next generation of ultramicrotomes, designed to significantly enhance laboratory productivity by combining precision engineering with advanced automation. Its automated setup functions streamline traditionally time-consuming preparation steps, reducing operator dependency and minimizing setup errors while ensuring consistently high-quality ultrathin sections.

James O'Brien, Vice President of Life Sciences at Leica Microsystems said

"UC Enuity helps to achieve precise and high-quality results consistently by automating critical steps in sample preparation. This automation makes this technology accessible and embodies our unwavering dedication to empower the scientific community to unlock new discoveries," "This built-to-last ultramicrotome has been designed with the future in mind. Researchers will be able to adapt their ultramicrotome as they expand their capabilities and maximize their scientific potential."

Latin America Microscope Market Trends

The industry in Latin America is expected to register considerable growth over the forecast period owing to the expanding investments in healthcare, research, and industrial infrastructure, which are gradually improving the accessibility and adoption of microscopy equipment across the region. Countries such as Brazil and Mexico are notable for their ongoing enhancements in healthcare and diagnostic capabilities, which boost demand for tools such as microscopes in clinical laboratories and medical research institutions.

The Brazil microscope marketheld the largest market share in 2025 driven by the launch of the Brazil-China Joint Synchrotron Science Laboratory at CNPEM in July 2025. The collaboration enhances Brazil’s access to international expertise, funding, and large-scale research projects, leading to increased demand for advanced optical, electron, and digital microscopes across national laboratories, universities, and affiliated research centers.

Andrea Brito Latgé, Secretary of Strategic Policies and Programs at MCTI said:

“We are very pleased with this agreement between CNPEM and IHEP, which strengthens a historic and strategic relationship between Brazil and China. This cooperation, especially in the field of synchrotron light sources, allows the exchange of experiences between laboratories with complementary expertise. There is a mutual desire to reinforce South-South cooperation, accelerating joint project development and involving young researchers, which is essential for advancing science, technology, and innovation in our countries,”

Middle East and Africa Microscope Market Trends

The industry in the Middle East & Africa (MEA) is driven by growing need for high-precision imaging technologies across multiple sectors. Governments, particularly in countries such as Saudi Arabia and the UAE, are prioritizing the modernization of research laboratories, medical facilities, and academic institutions by funding advanced equipment and fostering innovation as part of broader economic diversification initiatives such as Saudi Vision 2030, which accelerates adoption of cutting-edge microscopy tools in clinical, research, and industrial setting.

UAE microscope market is being driven by increasing visibility, availability, and applicability of advanced optical inspection tools across multiple sectors. For instance, SEP (Sigma Enterprises) showcases professional imaging systems such as the SZX-AR1 Augmented Reality Microscope System and the SZX 16 stereomicroscope, which highlight modern, high-performance microscopy solutions available locally in the UAE instead of requiring importation from overseas suppliers, reducing lead times and logistical barriers for buyers. By presenting these products as part of their instrumentation portfolio, SEP supports the adoption of microscopes in industrial inspection, quality control, research laboratories, and educational institutions throughout the country.

Key Microscope Company Insights

The market is fragmented, with the presence of many region & country level microscopes providers.The market players undertake several strategic initiatives, such as partnerships & collaborations, product launches, mergers & acquisitions, and geographical expansion to maintain their position and grow in the market.

Recent Developments

• In November 2025, Montana Technological University received a USD 25,014 grant from the Montana IDeA Network of Biomedical Research Excellence (INBRE) to enhance access to its advanced microscopy resources, including a high-powered Hitachi HT7820 electron microscope and a stereo microscope, by enabling remote access through videoconferencing tools and upgraded connectivity.

Biological Sciences Professor Marisa Pedulla said:

“With this funding, we’ll be able to greatly increase research, education, and STEM outreach,” “By developing remote access to the Hitachi HT7820, we aim to provide researchers with state-of-the-art instrumentation and students with transformative science education experiences.”

• In August 2025, EVIDENT’s acquired Pramana, Inc. reflecting a strategic move to strengthen its position in digital pathology and advanced imaging solutions. This acquisition supports the growing shift toward digital microscopy, remote diagnostics, and data-centric pathology, while enhancing workflow efficiency, collaboration, and clinical decision-making.

Wes Pringle, Evident CEO said:

“As the worldwide adoption of digital pathology continues to accelerate, our acquisition of Pramana represents a collaborative opportunity to expand our growing digital pathology product offering,” “Evident prides itself on pioneering new ways of helping the world see the unseen-this acquisition is an example of our commitment to bringing the most advanced solutions to our customers.”

• In July 2025, Thermo Fisher Scientific’s announced the launch of the Scios 3 FIB-SEM and Talos 12 TEM electron microscopes representing a significant advancement in high-resolution microscopy that broadens capability and accessibility for research and industrial applications.

• In July 2024, Danaher’s launched the Beacon research collaboration with Stanford University represents a strategic effort to develop the next generation of smart microscopes specifically designed for cancer drug screening. This initiative aims to integrate advanced imaging technologies with artificial intelligence and machine learning to enable automated, high-throughput analysis of cellular responses to potential cancer therapies.

Chandra Ramanathan, VP and Head of External Innovation of Danaher's DH Life Sciences LLC subsidiary, said:

"Many oncology drug trials fail because we cannot yet capture and analyze the nuances of the tumor microenvironment and how key proteins spatially interact with each other. Addressing this challenge will require collecting data at scale and designing new ways to analyze it. We are delighted to commit Danaher's expertise to seek to develop AI-driven phenotyping that could improve drug screening and bring more effective and safer drugs to cancer patients."

Microscope Market Report Scope

Global Microscope Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global microscope market report based on type, application, and region.

• Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • Optical Microscope

    • Upright Microscopes

    • Inverted Microscopes

    • Stereomicroscopes

    • Phase Contrast Microscopes

    • Fluorescence Microscopes

    • Confocal Scanning Microscopes

    • Near Field Scanning Microscopes

    • Other Optical Microscopes

  • Electron Microscope

    • Transmission Microscopes

    • Scanning Electron Microscopes

  • Scanning Probes Microscopes

  • Other Microscopes

• Application Outlook (Revenue, USD Billion, 2021 - 2033)

  • Material Science

  • Nanotechnology

  • Life Science

  • Semiconductors

  • Other Applications

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait